Development of a p62 biodegrader for autophagy targeted degradation

开发一种用于自噬靶向降解的p62生物降解剂

阅读:14
作者:Zacharias Thiel ,David Marcellin ,Carole Manneville ,Benedikt Goretzki ,Luca Egger ,Rob Maher ,Noémie Siccardi ,Laura Torres ,Alexandra Probst ,Catrin S Müller ,Nathalie George ,Markus Vogel ,Sabine Sinterhauf ,Alexandra Lavoisier ,Ji-Young Choi ,Laurianne Forcellino ,Alexandro Landshammer ,Patrick Hauck ,Celine Be ,Frédéric Villard ,Sascha Gutmann ,Marc Meyer ,Felix Freuler ,Alexandra Hinniger ,César Fernández ,Suzanne Chau ,Maude Patoor ,Gilles Sansig ,Gabriel Mitchell ,Beat Nyfeler

Abstract

Autophagy-based targeted degradation offers a powerful complement to proteasomal degradation leveraging the capacity and versatility of lysosomes to degrade complex cargo. However, it remains unclear which components of the autophagy-lysosomal pathway are most effective for targeted degradation. Here, we describe two orthogonal induced-proximity strategies to identify autophagy effectors capable of degrading organelles and soluble targets. Recruitment of autophagy cargo receptors, ATG8-like proteins, or the kinases ULK1 and TBK1 is sufficient to trigger mitophagy, while only autophagy cargo receptors capable of self-oligomerization degrade soluble cytosolic proteins. We further report a single-domain antibody against p62 and its use as a heterobifunctional degrader to clear mitochondria. Fusing the p62 single-domain antibody to PINK1 enables selective targeting of damaged mitochondria. Our study highlights the importance of avidity for targeted autophagy and suggests that autophagy cargo receptors are attractive entry points for the development of heterobifunctional degraders for organelles or protein aggregates.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。